pelvic inflammatory disease
Information
- Disease name
- pelvic inflammatory disease
- Disease ID
- DOID:1003
- Description
- "A female reproductive system disease that is characterized by an infection of the female reproductive organs." [url:https\://www.ncbi.nlm.nih.gov/pubmed/25992748]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03994055 | Active, not recruiting | N/A | Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer | November 16, 2018 | January 2024 |
| NCT03828994 | Active, not recruiting | N/A | Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II | February 10, 2019 | March 31, 2025 |
| NCT00683865 | Completed | Phase 3 | Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin. | April 2003 | October 2004 |
| NCT00783419 | Completed | Rate of Pelvic Inflammatory Disease at St. Michael's Hospital | March 2007 | January 2011 | |
| NCT00871494 | Completed | Phase 3 | Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan | May 2009 | November 2010 |
| NCT01160640 | Completed | Phase 2 | The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) | November 2010 | August 2015 |
| NCT01236131 | Completed | The Role of Novel Organisms in Acute Endometritis | November 2010 | August 2015 | |
| NCT01241110 | Completed | Phase 4 | To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment | January 2010 | September 2010 |
| NCT01299259 | Completed | N/A | Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease | February 2011 | October 2014 |
| NCT01671280 | Completed | Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) | September 20, 2012 | April 22, 2016 | |
| NCT01793584 | Completed | N/A | Surgical Success After Laparoscopic vs Abdominal Hysterectomy | February 2013 | December 31, 2016 |
| NCT01799356 | Completed | Phase 4 | Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials | June 2010 | March 2013 |
| NCT03054402 | Completed | Phase 1 | First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845 | February 13, 2017 | March 29, 2018 |
| NCT00115388 | Completed | N/A | Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease | September 2004 | December 2008 |
| NCT00453349 | Completed | Phase 3 | A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease | January 2007 | May 2008 |
| NCT04723069 | Completed | Phase 2 | Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases | September 21, 2021 | March 11, 2022 |
| NCT06360965 | Recruiting | N/A | Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain | January 1, 2024 | December 31, 2026 |
| NCT04567771 | Recruiting | N/A | Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer | December 4, 2020 | October 15, 2024 |
| NCT05408624 | Recruiting | Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses | July 15, 2022 | December 1, 2024 | |
| NCT05648747 | Recruiting | Pelvic Inflammatory Disease in COVID-19 Era | January 1, 2023 | January 30, 2024 | |
| NCT04234945 | Unknown status | N/A | Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity | January 13, 2020 | December 31, 2022 |
| NCT03391440 | Unknown status | Phase 4 | A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease | September 2016 | December 2018 |
| NCT02972151 | Unknown status | Phase 2 | Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae | November 2016 | December 2018 |
- Disase is a (Disease Ontology)
- DOID:229
- Cross Reference ID (Disease Ontology)
- ICD10CM:N73.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:614.9
- Cross Reference ID (Disease Ontology)
- MESH:D000292
- Cross Reference ID (Disease Ontology)
- NCI:C3889
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:266648001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0242172
- Exact Synonym (Disease Ontology)
- PID
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000292